Neuroloxía
Servizo
Fundación Jiménez Díaz
Madrid, EspañaPublicacións en colaboración con investigadores/as de Fundación Jiménez Díaz (46)
2024
-
Assessing illness-related uncertainty in relapsing-remitting multiple sclerosis: A psychometric analysis of the Mishel Uncertainty of Illness Scale
Multiple Sclerosis Journal - Experimental, Translational and Clinical, Vol. 10, Núm. 2
-
Therapeutic inertia in the management of neuromyelitis optica spectrum disorder
Frontiers in Neurology , Vol. 15
2023
-
Clinical utility of a personalized and long-term monitoring device for Parkinson's disease in a real clinical practice setting: An expert opinion survey on STAT-ON™
Neurologia, Vol. 38, Núm. 5, pp. 326-333
2022
-
Times to endovascular treatment following two triage models
Neurological Sciences, Vol. 43, Núm. 6, pp. 3967-3971
2021
2020
-
Amendment on the article “Missing outcome data management in acute stroke trials testing iv thrombolytics: Is there risk of bias?”
European Stroke Journal
-
Long-Term Anticoagulation in Secondary Ischemic Stroke Prevention: The Prospective Multicenter RESTAIC Registry
Frontiers in Neurology, Vol. 11
-
Spanish Cell Therapy Network (TerCel): 15 years of successful collaborative translational research
Cytotherapy, Vol. 22, Núm. 1, pp. 1-5
-
XII Reunión Post-ECTRIMS: revisión de las novedades presentadas en el Congreso ECTRIMS 2019 (I)
Revista de neurologia, Vol. 70, Núm. 10, pp. 379-390
-
XII Reunión Post-ECTRIMS: revisión de las novedades presentadas en el Congreso ECTRIMS 2019 (II)
Revista de neurologia, Vol. 70, Núm. 11, pp. 417-429
2019
-
Clinical outcomes of eslicarbazepine acetate monotherapy for focal-onset seizures: A multicenter audit
Acta Neurologica Scandinavica, Vol. 140, Núm. 6, pp. 422-428
2018
-
Common and rare TBK1 variants in early-onset Alzheimer disease in a European cohort
Neurobiology of Aging, Vol. 62, pp. 245.e1-245.e7
-
Mitos y evidencias en el empleo de la toxina botulínica: Neurofarmacología y distonías
Revista de Neurologia, Vol. 66, Núm. 5, pp. 163-172
2017
-
Assessment of plasma chitotriosidase activity, CCL18/PARC concentration and NP-C suspicion index in the diagnosis of Niemann-Pick disease type C: A prospective observational study
Journal of Translational Medicine, Vol. 15, Núm. 1
-
Deleterious ABCA7 mutations and transcript rescue mechanisms in early onset Alzheimer’s disease
Acta Neuropathologica, Vol. 134, Núm. 3, pp. 475-487
-
Efficacy and safety of eslicarbazepine-acetate in elderly patients with focal epilepsy: Case series
Seizure, Vol. 48, pp. 53-56
-
Erratum to “Safety, efficacy and outcome-related factors of perampanel over 12months in a real-world setting: The FYDATA study” [Epilepsy Res. (2016) 126 (201–210)] (S0920121116301218)(10.1016/j.eplepsyres.2016.08.001)
Epilepsy Research
-
Revisión de las novedades del XXXII Congreso ECTRIMS 2016, presentadas en la IX Reunión Post-ECTRIMS (II)
Revista de Neurologia, Vol. 65, Núm. 2, pp. 75-84
-
Revisión de las novedades del XXXII congreso ectrims 2016, presentadas en la ix reunión post-ectrims (I)
Revista de Neurologia, Vol. 65, Núm. 1, pp. 31-40